Investor Relations

Rigel's Mission

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematological disorders, cancer and rare immune diseases.

Recent Event

Rigel Conference Call to Discuss FORWARD Study Results

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Investor Contact Information

Company

Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080

Investor Relations

Rigel Pharmaceuticals, Inc.
ir@rigel.com

Transfer Agent

EQ Shareowner Services
T: 800-401-1957